Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dopamine receptor agonist' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 93 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Alexopoulos, GS
      "The depression-executive dysfunction syndrome of late life" - A specific target for D-3 agonists?

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    2. Becker, PM; Corrigan, MH; Kasper, S; Lin, SC; Montplaisir, J; Szegedi, A; Willner, P
      Clinical efficacy of pramipexole in the treatment of conditions other thanParkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    3. Armer, JA; Martin, WRW; Pogarell, O
      Tolerability and safety profile of pramipexole in the treatment of Parkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    4. Ikegami, H; Shishido, T; Ishida, K; Hanada, T; Nakayama, H; Doi, K
      Histopathological and immunohistochemical studies on arteritis induced by fenoldopam, a vasodilator, in rats

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    5. Garcia-Sanz, A; Badia, A; Clos, MV
      Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [H-3]-dopamine efflux from rat striatal synaptosomes

      SYNAPSE
    6. Andersson, KE
      Pharmacology of erectile function and dysfunction

      UROLOGIC CLINICS OF NORTH AMERICA
    7. Frances, H; Smirnova, M; Leyris, A; Aymard, N; Bourre, JM
      Influence of social isolation and 6-OHDA lesion on the effects of quinelorane

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    8. Muralikrishnan, D; Ebadi, M
      SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

      BRAIN RESEARCH
    9. Venkataraman, R; Kellum, JA
      Novel approaches to the treatment of acute renal failure

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Mukherjee, J; Narayanan, TK; Christian, BT; Shi, BZ; Dunigan, KA; Mantil, J
      In vitro and in vivo evaluation of the binding of the dopamine D2 receptoragonist C-11-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate

      SYNAPSE
    11. Salimov, RM; Salimova, NB; Shvets, LN; Maisky, AI
      Haloperidol administered subchronically reduces the alcohol-deprivation effect in mice

      ALCOHOL
    12. Li, L; Dowling, JE
      Effects of dopamine depletion on visual sensitivity of zebrafish

      JOURNAL OF NEUROSCIENCE
    13. Halpenny, M; Markos, F; Snow, HM; Duggan, PF; Gaffney, E; O'Connell, DP; Shorten, GD
      The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs

      EUROPEAN JOURNAL OF ANAESTHESIOLOGY
    14. Ott, MC; Costain, WJ; Mishra, RK; Johnson, RL
      L-prolyl-L-leucyl-glycinamide and its peptidomimetic analog 3 (R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum

      PEPTIDES
    15. Giuliano, F; Rampin, O
      Central neural regulation of penile erection

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    16. Casas, M; Prat, G; Robledo, P; Barbanoj, M; Kulisevsky, J; Jane, F
      Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    17. Thompson, TL; Moore, CC; Smith, B
      Estrogen priming modulates autoreceptor-mediated potentiation of dopamine uptake

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Rodenhuis, N; Timmerman, W; Wikstrom, HV; Dijkstra, D
      Thiophene analogs of naphthoxazines and 2-aminotetralins: bioisosteres with improved relative oral bioavailability, as compared to 5-OH-DPAT

      EUROPEAN JOURNAL OF PHARMACOLOGY
    19. Ekesbo, A; Andren, PE; Gunne, LM; Sonesson, C; Tedroff, J
      Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopaminelesions

      EUROPEAN JOURNAL OF PHARMACOLOGY
    20. Haile, CN; Carey, G; Varty, GB; Coffin, VL
      The dopamine D-1 receptor agonist SKF-82958 serves as a discriminative stimulus in the rat

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Meston, CM; Frohlich, PF
      The neurobiology of sexual function

      ARCHIVES OF GENERAL PSYCHIATRY
    22. Andringa, G; Vermeulen, RJ; Drukarch, B; Renier, WO; Stoof, JC; Cools, AR
      The validity of the pretreated, unilaterally MPTP-treated monkey as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF81297

      BEHAVIOURAL PHARMACOLOGY
    23. Ninan, I; Kulkarni, SK
      Antagonism by pimozide of olanzapine-induced hypothermia

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    24. Domino, EF; Ni, LS; Zhang, HL
      Nicotine alone and in combination with L-DOPA methyl ester or the D-2 agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys

      EXPERIMENTAL NEUROLOGY
    25. Lorenc-Koci, E; Wolfarth, S
      Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Moro, M; Inada, Y; Kojima, M; Miyata, H; Komatsu, H; Torii, R
      New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline

      EUROPEAN JOURNAL OF PHARMACOLOGY
    27. Andringa, G; Drukarch, B; Leysen, JE; Cools, AR; Stoof, JC
      The alleged dopamine D-1 receptor agonist SKF 83959 is a dopamine D-1 receptor antagonist in primate cells and interacts with other receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Cho, S; Duchemin, AM; Neff, NH; Hadjiconstantinou, M
      Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs

      BRAIN RESEARCH
    29. SOSKIC V; JOKSIMOVIC J
      BIOISOSTERIC APPROACH IN THE DESIGN OF NEW DOPAMINERGIC SEROTONERGIC LIGANDS/

      Current medicinal chemistry
    30. YATSU T; ARAI Y; TAKIZAWA K; KASAINAKAGAWA C; TAKANASHI M; UCHIDA W; INAGAKI O; TANAKA A; TAKENAKA T
      EFFECT OF YM435, A DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINE MODELOF ISCHEMIC ACUTE-RENAL-FAILURE

      General pharmacology
    31. YATSU T; ARAI Y; SUDOH K; SHIBASAKI M; UCHIDA W; INAGAKI O; TANAKA A; TAKENAKA T
      EFFECT OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINEMODEL OF ACUTE CONGESTIVE-HEART-FAILURE

      General pharmacology
    32. Pollentier, S; Brecht, HM
      Pramipexole - Preclinical and clinical data

      AKTUELLE NEUROLOGIE
    33. NOMOTO M; KITA S; IWATA SI; KASEDA S; FUKUDA T
      EFFECTS OF ACUTE OR PROLONGED ADMINISTRATION OF CABERGOLINE ON PARKINSONISM INDUCED BY MPTP IN COMMON MARMOSETS

      Pharmacology, biochemistry and behavior
    34. SARRE S; VANDENEEDE D; EBINGER G; MICHOTTE Y
      BIOTRANSFORMATION OF L-DOPA TO DOPAMINE IN THE SUBSTANTIA-NIGRA OF FREELY MOVING RATS - EFFECT OF DOPAMINE-RECEPTOR AGONISTS AND ANTAGONISTS

      Journal of neurochemistry
    35. DOMINO EF; NI LS; ZHANG HL; KOHNO Y; SASA M
      EFFECTS OF TALIPEXOLE ON CONTRAVERSIVE ROTATION AND FUNCTIONAL IMPAIRMENT IN MPTP-INDUCED CHRONIC HEMIPARKINSONIAN MONKEYS

      Japanese Journal of Pharmacology
    36. DURHAM RA; JOHNSON JD; EATON MJ; MOORE KE; LOOKINGLAND KJ
      OPPOSING ROLES FOR DOPAMINE D-1 AND D-2 RECEPTORS IN THE REGULATION OF HYPOTHALAMIC TUBEROINFUNDIBULAR DOPAMINE NEURONS

      European journal of pharmacology
    37. MALMBERG A; MOHELL N; HOOK BB; JOHANSSON AM; HACKSELL U; NORDVALL G
      INTERACTIONS OF LIGANDS WITH ACTIVE AND INACTIVE CONFORMATIONS OF THEDOPAMINE D-2 RECEPTOR

      European journal of pharmacology
    38. Weed, MR; Woolverton, WL; Paul, IA
      Dopamine D-1 and D-2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata

      EUROPEAN JOURNAL OF PHARMACOLOGY
    39. HAGINO H; TABUCHI E; KURACHI M; SAITOH O; SUN YJ; KONDOH T; ONO T; TORII K
      EFFECTS OF D-2 DOPAMINE-RECEPTOR AGONIST AND ANTAGONIST ON BRAIN ACTIVITY IN THE RAT ASSESSED BY FUNCTIONAL MAGNETIC-RESONANCE-IMAGING

      Brain research
    40. ANDREWS R; CHARLESWORTH A; EVANS A; COWLEY AJ
      A DOUBLE-BLIND, CROSS-OVER COMPARISON OF THE EFFECTS OF A LOOP DIURETIC AND A DOPAMINE-RECEPTOR AGONIST AS FIRST LINE THERAPY IN PATIENTS WITH MILD CONGESTIVE-HEART-FAILURE

      European heart journal
    41. KLECKER RW; COLLINS JM
      STEREOSELECTIVE METABOLISM OF FENOLDOPAM AND ITS METABOLITES IN HUMANLIVER-MICROSOMES, CYTOSOL, AND SLICES

      Journal of cardiovascular pharmacology
    42. YATSU T; TAKIZAWA K; KASAINAKAGAWA C; UCHIDA W; TANAKA A; ASANO M; HONDA K; TAKENAKA T
      HEMODYNAMIC CHARACTERIZATION OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN ANESTHETIZED DOGS

      Journal of cardiovascular pharmacology
    43. STEELE TD; HODGES DB; LEVESQUE TR; LOCKE KW
      D-1 AGONIST DIHYDREXIDINE RELEASES ACETYLCHOLINE AND IMPROVES COGNITIVE PERFORMANCE IN RATS

      Pharmacology, biochemistry and behavior
    44. KOWA H; KANAZAWA I; GOTO I; KUNO S; MIZUNO Y; OGAWA N; TASHIRO K; YANAGISAWA N
      9-YEAR FOLLOW-UP-STUDY OF BROMOCRIPTINE MONOTHERAPY FOR PARKINSONS-DISEASE

      European neurology
    45. CULVER KE; SZECHTMAN H
      MONOAMINE-OXIDASE INHIBITOR SENSITIVE SITE IMPLICATED IN SENSITIZATION TO QUINPIROLE

      European journal of pharmacology
    46. DURHAM RA; EATON MJ; MOORE KE; LOOKINGLAND KJ
      EFFECTS OF SELECTIVE ACTIVATION OF DOPAMINE D-2 AND D-3 RECEPTORS ON PROLACTIN SECRETION AND THE ACTIVITY OF TUBEROINFUNDIBULAR DOPAMINE NEURONS

      European journal of pharmacology
    47. DOMINO EF; NI LS; ZHANG HL; KOHNO Y; SASA M
      TALIPEXOLE OR PRAMIPEXOLE COMBINATIONS WITH CHLORO-APB (SKF-82958) INMPTP-INDUCED HEMIPARKINSONIAN MONKEYS

      European journal of pharmacology
    48. MAJ J; ROGOZ Z; SKUZA G; KOLODZIEJCZYK K
      THE BEHAVIORAL-EFFECTS OF PRAMIPEXOLE, A NOVEL DOPAMINE-RECEPTOR AGONIST

      European journal of pharmacology
    49. VANDENBUUSE M
      PRETREATMENT WITH QUINPIROLE INHIBITS THE CENTRAL ANTIHYPERTENSIVE EFFECTS OF RILMENIDINE AND ALPHA-METHYLDOPA IN CONSCIOUS RATS

      European journal of pharmacology
    50. YATSU T; ARAI Y; TAKIZAWA K; KASAINAKAGAWA C; TAKANASHI M; UCHIDA W; INAGAKI O; TANAKA A; ASANO M; HONDA K; TAKENAKA T
      RENAL EFFECT OF YM435, A NEW DOPAMINE D-1 RECEPTOR AGONIST, IN ANESTHETIZED DOGS

      European journal of pharmacology
    51. ZARRINDAST MR; OVEISI MR
      EFFECTS OF MONOAMINE RECEPTOR ANTAGONISTS ON NICOTINE-INDUCED HYPOPHAGIA IN THE RAT

      European journal of pharmacology
    52. KOHNO Y; FUKUZAKI K; KITAHARA K; KOJA T
      ANTI-TREMOR ACTIVITY OF TALIPEXOLE PRODUCED BY SELECTIVE DOPAMINE D-2RECEPTOR STIMULATION IN CYNOMOLGUS MONKEYS WITH UNILATERAL LESIONS INTHE VENTROMEDIAL TEGMENTUM

      European journal of pharmacology
    53. ARAI N; ISAJI M; KOJIMA M; MIZUTA E; KUNO S
      COMBINED EFFECTS OF CABERGOLINE AND L-DOPA ON PARKINSONISM IN MPTP-TREATED CYNOMOLGUS MONKEYS

      Journal of neural transmission
    54. LITTEN RZ; ALLEN J; FERTIG J
      PHARMACOTHERAPIES FOR ALCOHOL-PROBLEMS - A REVIEW OF RESEARCH WITH FOCUS ON DEVELOPMENTS SINCE 1991

      Alcoholism, clinical and experimental research
    55. RODGERS RJ; JOHNSON NJT; CHAMPION AJ; MILLS S
      MODULATION OF PLUS-MAZE BEHAVIOR IN MICE BY THE PREFERENTIAL D-3-RECEPTOR AGONIST 7-OH-DPAT

      Pharmacology, biochemistry and behavior
    56. GLASE SA; AKUNNE HC; HEFFNER TG; JAEN JC; MACKENZIE RG; MELTZER LT; PUGSLEY TA; SMITH SJ; WISE LD
      ARYL 1-BUT-3-YNYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINES AS POTENTIAL ANTIPSYCHOTIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    57. TASHIRO K; GOTO I; KANAZAWA I; KOWA H; KUNO S; MIZUNO Y; OGAWA N; YANAGISAWA N
      8-YEAR FOLLOW-UP-STUDY OF BROMOCRIPTINE MONOTHERAPY FOR PARKINSONS-DISEASE

      European neurology
    58. PIERCEY MF; HOFFMANN WE; SMITH MW; HYSLOP DK
      INHIBITION OF DOPAMINE NEURON FIRING BY PRAMIPEXOLE, A DOPAMINE D-3 RECEPTOR-PREFERRING AGONIST, COMPARISON TO OTHER DOPAMINE-RECEPTOR AGONISTS

      European journal of pharmacology
    59. NG GYK; ODOWD BF; GEORGE SR
      GENOTYPIC DIFFERENCES IN MESOLIMBIC ENKEPHALIN GENE-EXPRESSION IN DBA2J AND C57BL/6J INBRED MICE/

      European journal of pharmacology
    60. BLANCHET PJ; GRONDIN R; BEDARD PJ; SHIOSAKI K; BRITTON DR
      DOPAMINE D-1 RECEPTOR DESENSITIZATION PROFILE IN MPTP-LESIONED PRIMATES

      European journal of pharmacology
    61. BONO G; BALDUCCI C; RICHELMI P; KOOB GF; PULVIRENTI L
      DOPAMINE PARTIAL RECEPTOR AGONISTS REDUCE ETHANOL INTAKE IN THE RAT

      European journal of pharmacology
    62. SARRE S; EBINGER G; MICHOTTE Y
      LEVODOPA BIOTRANSFORMATION IN HEMI-PARKINSON RATS - EFFECT OF DOPAMINE-RECEPTOR AGONISTS AND ANTAGONISTS

      European journal of pharmacology
    63. NADAL R; PRAT G; PALLARES M; HERNANDEZTORRES M; FERRE N
      EFFECTS OF BROMOCRIPTINE ON SELF-ADMINISTRATION OF SWEETENED ETHANOL SOLUTIONS IN RATS

      Psychopharmacology
    64. CASTELNOVO P; ALBANESI C
      DETERMINATION OF THE ENANTIOMERIC PURITY OF DIHYDROXY-2-AMINOTETRALINS AND DIMETHOXY-2-AMINOTETRALINS BY HIGH-PERFORMANCE CAPILLARY ELECTROPHORESIS WITH CYCLODEXTRINS AS CHIRAL SELECTOR

      Chirality
    65. SCHINDLER CW; TELLA SR; ERZOUKI HK; GOLDBERG SR
      PHARMACOLOGICAL MECHANISMS IN COCAINE CARDIOVASCULAR EFFECTS

      Drug and alcohol dependence
    66. OHBU K; KASKEL FJ; KINOSHITA S; FELDER RA
      DOPAMINE-1 RECEPTORS IN THE PROXIMAL CONVOLUTED TUBULE OF DAHL RATS -DEFECTIVE COUPLING TO ADENYLATE-CYCLASE

      American journal of physiology. Regulatory, integrative and comparative physiology
    67. CARLSSON A
      TOWARDS A NEW UNDERSTANDING OF DOPAMINE-RECEPTORS

      Clinical neuropharmacology
    68. CHASE TN; METMAN LV; BRAVI D; ROBERTS JW; SIBLEY DR; MOURADIAN MM
      DOPAMINE-RECEPTOR SUBTYPE-SELECTIVE AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE

      Clinical neuropharmacology
    69. KLINGPETERSEN T; LJUNG E; SVENSSON K
      EFFECTS ON LOCOMOTOR-ACTIVITY AFTER LOCAL APPLICATION OF D3 PREFERRING COMPOUNDS IN DISCRETE AREAS OF THE RAT-BRAIN

      Journal of neural transmission
    70. SACHS BD
      PLACING ERECTION IN CONTEXT - THE REFLEXOGENIC PSYCHOGENIC DICHOTOMY RECONSIDERED

      Neuroscience and biobehavioral reviews
    71. FERRAZ MR; SANTOS R
      AMANTADINE STIMULATES SEXUAL-BEHAVIOR IN MALE-RATS

      Pharmacology, biochemistry and behavior
    72. VANDENBUUSE M
      DIFFERENTIAL-EFFECTS OF QUINELORANE AND PERGOLIDE ON BEHAVIOR, BLOOD-PRESSURE, AND BODY-TEMPERATURE OF SPONTANEOUSLY HYPERTENSIVE RATS AND WISTAR-KYOTO RATS

      Pharmacology, biochemistry and behavior
    73. GANCHER S; CRABBE J; GARLAND A; LEA E; WOODWARD W
      DOSE-DEPENDENT AND DURATION-DEPENDENT TOLERANCE TO ROTATIONAL EFFECTSOF APOMORPHINE IN A RAT MODEL OF PARKINSONISM

      The Journal of pharmacology and experimental therapeutics
    74. EMADUDDIN M; LIU GJ; TAKEUCHI H
      EFFECTS OF DOPAMINE ON SNAIL NEURONS

      European journal of pharmacology
    75. JACKSON DM; MOHELL N; BENGTSSON A; MALMBERG A
      WHY DOES CLOZAPINE STIMULATE THE MOTOR-ACTIVITY OF RESERPINE-PRETREATED RATS WHEN COMBINED WITH A DOPAMINE D-1 RECEPTOR AGONIST

      European journal of pharmacology
    76. KUJACIC M; CARLSSON A
      IN-VIVO ACTIVITY OF TYROSINE-HYDROXYLASE IN RAT ADRENAL-GLANDS FOLLOWING ADMINISTRATION OF QUINPIROLE AND DOPAMINE

      European journal of pharmacology
    77. IRIFUNE M; NOMOTO M; FUKUDA T
      EFFECTS OF GBR-12909 ON LOCOMOTOR-ACTIVITY AND DOPAMINE TURNOVER IN MICE - COMPARISON WITH APOMORPHINE

      European journal of pharmacology
    78. FECHTALI T; ISSOUAL D; ABRAINI JH
      D1 RECEPTORS MODULATE STRIATAL DOPAMINE RELEASE INDUCED BY THE STIMULATION OF BOTH D1 AND D2 RECEPTORS - IN-VIVO VOLTAMMETRIC DATA REVISITED

      JOURNAL OF PHYSIOLOGY-PARIS
    79. NG GYK; GEORGE SR
      DOPAMINE-RECEPTOR AGONIST REDUCES ETHANOL SELF-ADMINISTRATION IN THE ETHANOL-PREFERRING C57BL 6J INBRED MOUSE/

      European journal of pharmacology. Molecular pharmacology section
    80. NAKAZAWA K; AKIYAMA T; INOUE K
      BLOCK BY APOMORPHINE OF ACETYLCHOLINE-RECEPTOR CHANNELS EXPRESSED IN XENOPUS OOCYTES

      European journal of pharmacology. Molecular pharmacology section
    81. KINTER LB; MANN WA; WEINSTOCK J; RUFFOLO RR
      EFFECTS OF CATECHOL RING FLUORINATION ON CARDIOVASCULAR AND RENAL ACTIVITIES OF FENOLDOPAM ENANTIOMERS

      Chirality
    82. OLANOW CW; FAHN S; MUENTER M; KLAWANS H; HURTIG H; STERN M; SHOULSON I; KURLAN R; GRIMES JD; JANKOVIC J; HOEHN M; MARKHAM CH; DUVOISIN R; REINMUTH O; LEONARD HA; AHLSKOG E; FELDMAN R; HERSHEY L; YAHR MD
      A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PERGOLIDE AS AN ADJUNCT TO SINEMET(R) IN PARKINSONS-DISEASE

      Movement disorders
    83. YUE JL; UEDA H; MISU Y
      EVIDENCE FOR A DOPAMINE-RECEPTOR SUBTYPE SENSITIVE TO COMBINATION OF D1 WITH D2 ANTAGONIST IN MEASUREMENT OF G-PROTEIN ACTIVITY USING RAT STRIATAL MEMBRANES

      Life sciences
    84. PIERCEY MF; TANG AH; LAHTI RA; VONVOIGTLANDER PF; SCHREUR PJKD; MCCALL RB; LUMRAGAN JT; HOFFMANN WE; FRANKLIN SR; CODE RA; SMITH MW; SZMUSZKOVICZ J
      PHARMACOLOGY OF A MIXED 5-HYDROXYTRYPTAMINE(1A) DOPAMINE AGONIST/

      The Journal of pharmacology and experimental therapeutics
    85. IRIFUNE M; NOMOTO M; FUKUDA T
      ANTIPARKINSONIAN ACTIVITY OF TALIPEXOLE IN MPTP-TREATED MONKEYS - IN COMBINATION WITH L-DOPA AND AS CHRONIC TREATMENT

      European journal of pharmacology
    86. IRIFUNE M; NOMOTO M; FUKUDA T
      ANTIPARKINSONIAN ACTIVITY OF TALIPEXOLE IN MPTP-TREATED MONKEYS - IN COMBINATION WITH L-DOPA AND AS CHRONIC TREATMENT

      European journal of pharmacology
    87. DAQUILA PS; COLLU M; PANI L; GESSA GL; SERRA G
      ANTIDEPRESSANT-LIKE EFFECT OF SELECTIVE DOPAMINE D-1 RECEPTOR AGONISTS IN THE BEHAVIORAL DESPAIR ANIMAL-MODEL OF DEPRESSION

      European journal of pharmacology
    88. MOY SS; BREESE GR; ECKERMAN DA
      ALTERED ACTIVITY PATTERNS FOLLOWING NEONATAL 6-HYDROXYDOPAMINE LESIONS TO DOPAMINERGIC-NEURONS - EFFECT OF SKF-38393

      Brain research
    89. ABRAINI JH; FECHTALI T; ROSTAIN JC
      LASTING EFFECTS OF DOPAMINE-RECEPTOR AGONISTS UPON STRIATAL DOPAMINE RELEASE IN FREE-MOVING RATS - AN IN-VIVO VOLTAMMETRIC STUDY

      Brain research
    90. CASTELNOVO P
      DETERMINATION OF THE ENANTIOMERIC PURITY OF 5,6-DIHYDROXY-2-AMINOTETRALINS AND 6,7-DIHYDROXY-2-AMINOTETRALINS BY CHIRAL HPLC

      Chirality
    91. STARR MS; STARR BS
      FACILITATION OF DOPAMINE-D(1) RECEPTOR-DEPENDENT BUT NOT DOPAMINE D(1) D(2) RECEPTOR-DEPENDENT LOCOMOTION BY GLUTAMATE ANTAGONISTS IN THE RESERPINE-TREATED MOUSE/

      European journal of pharmacology
    92. POTTER DE; OGIDIGBEN MJ; HEATH AR
      OCULAR ACTIONS OF AN OCTAHYDROBENZO[F]QUINOLINE - HA117

      European journal of pharmacology
    93. HACKMAN BB; GRIFFIN B; MILLS M; RAMANATHAN KB
      COMPARATIVE EFFECTS OF FENOLDOPAM MESYLATE AND NITROPRUSSIDE ON LEFT-VENTRICULAR PERFORMANCE IN SEVERE SYSTEMIC HYPERTENSION

      The American journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 23:38:56